XML 35 R4.htm IDEA: XBRL DOCUMENT v3.26.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Cash flows from operating activities    
Income (loss) for the year $ 1,772 $ (364)
Adjustments for:    
Depletion and depreciation 16,359 7,218
Impairment charge (Note 9) 2,017 436
Share-based compensation expense (Note 14) 2,436 1,388
Share of profit of associates (Note 9) (2,203) (2,036)
Loss (gain) on revaluation of financial instruments (769) 5
Interest and finance expenses (Note 12) 478 2,028
Tax expense (Note 13) 4,508 1,321
Other non-cash movements (Note 22) 3,245 (893)
Accounts receivable 5,598 (2,537)
Accounts payable and accrued liabilities 568 (479)
Total cash provided by operating activities before taxes 34,009 6,087
Taxes paid (3,198) (1,271)
Total cash provided by operating activities 30,811 4,816
Cash flows from investing activities    
Distributions from SLM California (Note 9) 3,126 3,922
Acquisition of royalty interests (Note 8) (68,697) (3,241)
Net cash received from the purchase of EMX Royalty Corp. (Note 4) 3,097 0
Proceeds from royalty buy-back (Note 8) 1,913 0
Proceeds from the sale of investments 5,231 3,500
Purchase of Tether Gold cryptocurrency tokens (Note 7) (1,000) 0
Other movements (Note 22) 5 333
Total cash provided by (used in) investing activities (56,325) 4,514
Cash flows from financing activities    
Interest received 507 198
Interest paid (408) (1,979)
Loan repayments (Note 12) (28,000) (27,000)
Proceeds from private placement (Note 13 and 18) 100,000 12,763
Share issue costs (227) (91)
Proceeds from exercise of options and settlement of PSUs (Note 14) 2,674 0
Finance lease payments 10 0
Total cash provided by (used in) financing activities 74,556 (16,109)
Effect of exchange rate changes on cash and cash equivalents (353) (54)
Change in cash and cash equivalents 48,689 (6,833)
Cash and cash equivalents, beginning 4,454 11,287
Cash and cash equivalents, ending $ 53,143 $ 4,454